Age 0 3 0 3 B-age
≥18 4 7 4 7 O
and 8 11 8 11 O
≤ 12 13 12 13 O
80 14 16 14 16 B-upper_bound
years 17 22 17 22 I-upper_bound

Cytostatic 0 10 23 33 B-treatment
therapy 11 18 34 41 I-treatment
/ 19 20 42 43 O
chemotherapy 21 33 44 56 B-treatment
for 34 37 57 60 O
cancer 38 44 61 67 B-cancer
within 45 51 68 74 O
the 52 55 75 78 O
past 56 60 79 83 B-upper_bound
5 61 62 84 85 I-upper_bound
years 63 68 86 91 I-upper_bound

History 0 7 92 99 O
of 8 10 100 102 O
cancers 11 18 103 110 B-cancer
or 19 21 111 113 O
other 22 27 114 119 O
comorbidities 28 41 120 133 O
that 42 46 134 138 O
limit 47 52 139 144 O
life 53 57 145 149 B-clinical_variable
expectancy 58 68 150 160 I-clinical_variable
to 69 71 161 163 O
less 72 76 164 168 O
than 77 81 169 173 O
five 82 86 174 178 B-upper_bound
years 87 92 179 184 I-upper_bound

IORT 0 4 185 189 B-clinical_variable
dose 5 9 190 194 I-clinical_variable
> 10 11 195 196 O
8 11 12 196 197 B-lower_bound
Gy 13 15 198 200 I-lower_bound
to 16 18 201 203 O
any 19 22 204 207 O
risk 23 27 208 212 O
organ 28 33 213 218 O

IORT 0 4 219 223 B-treatment
must 5 9 224 228 O
be 10 12 229 231 O
technically 13 24 232 243 O
feasible 25 33 244 252 O

Karnofsky 0 9 253 262 B-clinical_variable
Performance 10 21 263 274 I-clinical_variable
Score 22 27 275 280 I-clinical_variable
( 28 29 281 282 I-clinical_variable
KPS 29 32 282 285 I-clinical_variable
) 32 33 285 286 I-clinical_variable
≥ 34 35 287 288 O
60 36 38 289 291 B-lower_bound
% 38 39 291 292 I-lower_bound

Multicentric 0 12 293 305 B-chronic_disease
disease 13 20 306 313 I-chronic_disease
( 21 22 314 315 O
e.g. 22 26 315 319 O
in 27 29 320 322 O
both 30 34 323 327 O
hemispheres 35 46 328 339 O
) 46 47 339 340 O

Participation 0 13 341 354 O
in 14 16 355 357 O
other 17 22 358 363 B-treatment
clinical 23 31 364 372 I-treatment
trials 32 38 373 379 I-treatment
testing 39 46 380 387 O
cancer 47 53 388 394 O
- 53 54 394 395 O
derived 54 61 395 402 O
investigational 62 77 403 418 B-treatment
agents 78 84 419 425 I-treatment
/ 84 85 425 426 I-treatment
procedures 85 95 426 436 I-treatment

Patient 0 7 437 444 O
's 7 9 444 446 O
written 10 17 447 454 O
IC 18 20 455 457 B-chronic_disease
obtained 21 29 458 466 O
at 30 32 467 469 O
least 33 38 470 475 O
24h 39 42 476 479 B-lower_bound
prior 43 48 480 485 I-lower_bound
to 49 51 486 488 O
surgery 52 59 489 496 B-treatment

Platelets 0 9 497 506 B-clinical_variable
≥ 10 11 507 508 O
75.000 12 18 509 515 B-lower_bound
/ 18 19 515 516 I-lower_bound
μL 19 21 516 518 I-lower_bound

Pregnant 0 8 519 527 B-pregnancy

Previous 0 8 528 536 O
cranial 9 16 537 544 B-treatment
radiation 17 26 545 554 I-treatment
therapy 27 34 555 562 I-treatment

Previous 0 8 563 571 O
therapy 9 16 572 579 O
with 17 21 580 584 O
anti 22 26 585 589 B-treatment
- 26 27 589 590 I-treatment
angiogenic 27 37 590 600 I-treatment
substances 38 48 601 611 I-treatment
( 49 50 612 613 O
such 50 54 613 617 O
as 55 57 618 620 O
bevacizumab 58 69 621 632 B-treatment
) 69 70 632 633 O

Serum 0 5 634 639 B-clinical_variable
Creatinine 6 16 640 650 I-clinical_variable
≤ 17 18 651 652 O
1.5 19 22 653 656 B-upper_bound
times 23 28 657 662 I-upper_bound
ULN 29 32 663 666 I-upper_bound

Supratentorial 0 14 667 681 B-chronic_disease
T1 15 17 682 684 I-chronic_disease
- 17 18 684 685 I-chronic_disease
Gd 18 20 685 687 I-chronic_disease
enhancing 21 30 688 697 O
lesion(s 31 39 698 706 O
) 39 40 706 707 O
amenable 41 49 708 716 O
to 50 52 717 719 O
total 53 58 720 725 O
resection 59 68 726 735 O

Total 0 5 736 741 B-clinical_variable
Serum 6 11 742 747 I-clinical_variable
Bilirubin 12 21 748 757 I-clinical_variable
< 22 23 758 759 O
1.5 24 27 760 763 B-upper_bound
times 28 33 764 769 I-upper_bound
ULN 34 37 770 773 I-upper_bound

